CALGARY, ALBERTA - March 4, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the commencement of the Frances Creek ...
Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch
CALGARY, ALBERTA - April 1, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the successful completion of a key ...
Positive feedback received after completion of CDC tests on 24 subjects All key product performance milestones met or exceeded expectations Voyageur believes it is now a player in the contrast media ...
Bracco Diagnostics announced that the Food and Drug Administration (FDA) has approved E-Z-HD (barium sulfate) for oral suspension for use in double-contrast radiographic examinations of the esophagus, ...
Is single-contrast barium enema acceptable management for the patient following unsuccessful colonoscopy? Is air contrast better, or should a repeat colonoscopy be planned? The question posed is ...
CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...
Bracco Diagnostics announced that the FDA has approved a New Drug Application (NDA) for READI-CAT 2 and READI-CAT 2 SMOOTHIE (barium sulfate) oral suspension for use in computed tomography (CT) of the ...
Calgary, Alberta, Canada – April 23, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback